{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:01:46Z","timestamp":1781229706193,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007623","name":"School of Medicine, Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG054046"],"award-info":[{"award-number":["R01 AG054046"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s13311-022-01305-9","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T14:03:58Z","timestamp":1666793038000},"page":"245-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["CSF IL-8 Associated with Response to Gene Therapy in a Case Series of Spinal Muscular Atrophy"],"prefix":"10.1016","volume":"20","author":[{"given":"Sumit","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Razdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Christina","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice L.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4862-6777","authenticated-orcid":false,"given":"William T.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1007\/s13311-022-01305-9_bib1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ana.25101","article-title":"Natural history of infantile-onset spinal muscular atrophy","volume":"82","author":"Kolb","year":"2017","journal-title":"Ann Neurol"},{"issue":"18","key":"10.1007\/s13311-022-01305-9_bib2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1007\/s13311-022-01305-9_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150640","article-title":"SMN protein can be reliably measured in whole blood with an electrochemiluminescence (ECL) immunoassay: implications for clinical trials","volume":"11","author":"Zaworski","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1007\/s13311-022-01305-9_bib4","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1172\/JCI124120","article-title":"Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment","volume":"129","author":"Ramos","year":"2019","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1007\/s13311-022-01305-9_bib5","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00415-019-09389-8","article-title":"NFL is a marker of treatment response in children with SMA treated with nusinersen","volume":"266","author":"Olsson","year":"2019","journal-title":"J Neurol"},{"issue":"1","key":"10.1007\/s13311-022-01305-9_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00415-019-09547-y","article-title":"Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen","volume":"267","author":"Wurster","year":"2020","journal-title":"J Neurol"},{"issue":"5","key":"10.1007\/s13311-022-01305-9_bib7","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1111\/jcmm.14939","article-title":"Nusinersen treatment and cerebrospinal fluid neurofilaments: an explorative study on Spinal Muscular Atrophy type 3 patients","volume":"24","author":"Faravelli","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1007\/s13311-022-01305-9_bib8","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3233\/JAD-190941","article-title":"Cerebrospinal fluid levels of interleukin-8 in delirium, dementia, and cognitively healthy patients","volume":"73","author":"Sajjad","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1007\/s13311-022-01305-9_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-010-0723-9","article-title":"Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease","volume":"120","author":"Hu","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"21","key":"10.1007\/s13311-022-01305-9_bib10","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1523\/JNEUROSCI.3472-16.2017","article-title":"Decreased motor neuron support by SMA astrocytes due to diminished MCP1 secretion","volume":"37","author":"Martin","year":"2017","journal-title":"J Neurosci"},{"issue":"4","key":"10.1007\/s13311-022-01305-9_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/PEP.0b013e3182351f04","article-title":"Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND)","volume":"23","author":"Glanzman","year":"2011","journal-title":"Pediatr Phys Ther"},{"issue":"5","key":"10.1007\/s13311-022-01305-9_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/mus.26909","article-title":"Motor unit number index in children with later-onset spinal muscular atrophy","volume":"62","author":"Verma","year":"2020","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1007\/s13311-022-01305-9_bib13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.tins.2007.08.007","article-title":"Neuronal 'On' and 'Off' signals control microglia","volume":"30","author":"Biber","year":"2007","journal-title":"Trends Neurosci"},{"issue":"7","key":"10.1007\/s13311-022-01305-9_bib14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nn1715","article-title":"Control of microglial neurotoxicity by the fractalkine receptor","volume":"9","author":"Cardona","year":"2006","journal-title":"Nat Neurosci"},{"issue":"13","key":"10.1007\/s13311-022-01305-9_bib15","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1523\/JNEUROSCI.2841-16.2017","article-title":"Deletion of the fractalkine receptor, CX3CR1, improves endogenous repair, axon sprouting, and synaptogenesis after spinal cord injury in mice","volume":"37","author":"Freria","year":"2017","journal-title":"J Neurosci"},{"issue":"2","key":"10.1007\/s13311-022-01305-9_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jcb.20052","article-title":"Regulation of neuroinflammation: the role of CXCL10 in lymphocyte infiltration during autoimmune encephalomyelitis","volume":"92","author":"Klein","year":"2004","journal-title":"J Cell Biochem"},{"issue":"5","key":"10.1007\/s13311-022-01305-9_bib17","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.4049\/jimmunol.165.5.2327","article-title":"The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease","volume":"165","author":"Liu","year":"2000","journal-title":"J Immunol"},{"issue":"1","key":"10.1007\/s13311-022-01305-9_bib18","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1038\/s41598-020-62756-8","article-title":"Peripheral proinflammatory Th1\/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis","volume":"10","author":"Jin","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"10.1007\/s13311-022-01305-9_bib19","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.4049\/jimmunol.149.7.2358","article-title":"Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha","volume":"149","author":"Aloisi","year":"1992","journal-title":"J Immunol"},{"issue":"4","key":"10.1007\/s13311-022-01305-9_bib20","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.4049\/jimmunol.160.4.1944","article-title":"Cytokine regulation of human microglial cell IL-8 production","volume":"160","author":"Ehrlich","year":"1998","journal-title":"J Immunol"},{"issue":"11","key":"10.1007\/s13311-022-01305-9_bib21","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.4049\/jimmunol.180.11.7112","article-title":"Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-\u03b2 are resistant to Th17 conversion by IL-6","volume":"180","author":"Zheng","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1007\/s13311-022-01305-9_bib22","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1038\/s41598-019-45418-2","article-title":"Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder","volume":"9","author":"Ozturk","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1007\/s13311-022-01305-9_bib23","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1038\/s41467-020-19177-y","article-title":"Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow","volume":"11","author":"Mishra","year":"2020","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-022-01305-9_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fneur.2016.00195","article-title":"Immununochemical markers of the amyloid cascade in the hippocampus in motor neuron diseases","volume":"7","author":"Gomez-Pinedo","year":"2016","journal-title":"Front Neurol"},{"key":"10.1007\/s13311-022-01305-9_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fimmu.2019.00480","article-title":"CSF cytokines in aging, multiple sclerosis, and dementia","volume":"10","author":"Hu","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1007\/s13311-022-01305-9_bib26","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1038\/s41467-021-24220-7","article-title":"Alzheimer's disease neuroimaging I. Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer's disease","volume":"12","author":"Hu","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1007\/s13311-022-01305-9_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13195-017-0315-1","article-title":"Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers","volume":"9","author":"Howell","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"10.1007\/s13311-022-01305-9_bib28","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3201\/eid2609.202122","article-title":"Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA, 2020","volume":"26","author":"Benameur","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1007\/s13311-022-01305-9_bib29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/acn3.51276","article-title":"Type I SMA new natural history: long-term data in nusinersen-treated patients","volume":"8","author":"Pane","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"10.1007\/s13311-022-01305-9_bib30","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"Rosengren","year":"1996","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"10.1007\/s13311-022-01305-9_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0165-5728(01)00455-6","article-title":"Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability","volume":"122","author":"Semra","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1007\/s13311-022-01305-9_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13195-018-0426-3","article-title":"Non-beta-amyloid\/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease","volume":"10","author":"Gangishetti","year":"2018","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"10.1007\/s13311-022-01305-9_bib33","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.neurobiolaging.2011.05.013","article-title":"Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers","volume":"33","author":"Kester","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"7","key":"10.1007\/s13311-022-01305-9_bib34","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/acn3.51078","article-title":"Longitudinal biomarkers in amyotrophic lateral sclerosis","volume":"7","author":"Huang","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1007\/s13311-022-01305-9_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","article-title":"A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis","volume":"72","author":"Mitchell","year":"2009","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1007\/s13311-022-01305-9_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2010.03.004","article-title":"CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis","volume":"222","author":"Tateishi","year":"2010","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1007\/s13311-022-01305-9_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mus.20376","article-title":"Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis","volume":"32","author":"Baron","year":"2005","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1007\/s13311-022-01305-9_bib38","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1468-1331.2009.02560.x","article-title":"Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis","volume":"16","author":"Kuhle","year":"2009","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1007\/s13311-022-01305-9_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/nan.12511","article-title":"Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis","volume":"45","author":"Gille","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"10.1007\/s13311-022-01305-9_bib40","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/acn3.51078","article-title":"Longitudinal biomarkers in amyotrophic lateral sclerosis","volume":"7","author":"Huang","year":"2020","journal-title":"Ann Clin Trans Neurol"},{"key":"10.1007\/s13311-022-01305-9_bib41","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fneur.2018.00384","article-title":"A role for GDNF and soluble APP as biomarkers of amyotrophic lateral sclerosis pathophysiology","volume":"9","author":"Stanga","year":"2018","journal-title":"Front Neurol"},{"issue":"2","key":"10.1007\/s13311-022-01305-9_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/acn3.162","article-title":"SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice","volume":"2","author":"Dirren","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"issue":"14","key":"10.1007\/s13311-022-01305-9_bib43","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1093\/hmg\/ddv148","article-title":"Astrocytes influence the severity of spinal muscular atrophy","volume":"24","author":"Rindt","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1007\/s13311-022-01305-9_bib44","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1523\/JNEUROSCI.5775-11.2012","article-title":"Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction","volume":"32","author":"Gogliotti","year":"2012","journal-title":"J Neurosci"},{"issue":"9","key":"10.1007\/s13311-022-01305-9_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075866","article-title":"Improvement of neuromuscular synaptic phenotypes without enhanced survival and motor function in severe spinal muscular atrophy mice selectively rescued in motor neurons","volume":"8","author":"Paez-Colasante","year":"2013","journal-title":"PLoS One"},{"key":"10.1007\/s13311-022-01305-9_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.653821","article-title":"Detailed postmortem profiling of inflammatory mediators expression revealed post-inflammatory alternation in the superior temporal gyrus of schizophrenia","volume":"12","author":"Izumi","year":"2021","journal-title":"Front Psychiatry"},{"issue":"6","key":"10.1007\/s13311-022-01305-9_bib47","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.4049\/jimmunol.158.6.2882","article-title":"Expression of chemokine receptors by subsets of neurons in the central nervous system","volume":"158","author":"Horuk","year":"1997","journal-title":"J Immunol"},{"key":"10.1007\/s13311-022-01305-9_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105538","article-title":"CXCR2 increases in ALS cortical neurons and its inhibition prevents motor neuron degeneration in vitro and improves neuromuscular function in SOD1G93A mice","volume":"160","author":"La Cognata","year":"2021","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1007\/s13311-022-01305-9_bib49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/00003246-200004000-00003","article-title":"Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury","volume":"28","author":"Whalen","year":"2000","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1007\/s13311-022-01305-9_bib50","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/neu.2009.1080","article-title":"Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury","volume":"27","author":"Kwon","year":"2010","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-022-01305-9_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.866153","article-title":"CSF biomarkers in COVID-19 associated encephalopathy and encephalitis predict long-term outcome","volume":"13","author":"Guasp","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1007\/s13311-022-01305-9_bib52","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jnnp-2018-317969","article-title":"CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications","volume":"89","author":"Kaneko","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1007\/s13311-022-01305-9_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092325","article-title":"Human astrocytes: Secretome profiles of cytokines and chemokines","volume":"9","author":"Choi","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1007\/s13311-022-01305-9_bib54","doi-asserted-by":"crossref","first-page":"E2347","DOI":"10.1073\/pnas.1613181114","article-title":"SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage","volume":"114","author":"Jangi","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-022-01305-9_bib55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neurobiolaging.2020.02.011","article-title":"A three-dimensional dementia model reveals spontaneous cell cycle re-entry and a senescence-associated secretory phenotype","volume":"90","author":"Porterfield","year":"2020","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1007\/s13311-022-01305-9_bib56","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004647-199703000-00005","article-title":"Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production","volume":"17","author":"Kossmann","year":"1997","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-022-01305-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:34:17Z","timestamp":1761806057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1878747923001198"],"URL":"https:\/\/doi.org\/10.1007\/s13311-022-01305-9","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF IL-8 Associated with Response to Gene Therapy in a Case Series of Spinal Muscular Atrophy","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01305-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Author(s). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}